The accuracy of mammography, sonography and magnetic resonance imaging (MRI) in
identifying residual disease after neoadjuvant chemotherapy is evaluated and imaging …

OBJECTIVE. The objective of our study was to determine the relative accuracy of
mammography, sonography, and MRI in predicting residual tumor after neoadjuvant …

BACKGROUND The implementation of new treatment protocols for locally advanced breast
cancer is currently limited by inaccurate evaluation of response to neoadjuvant …

Objectives: The purpose of this study was to determine the relative accuracies of
mammography, sonography, MRI and clinical examination in predicting residual tumour size …

AIM: To assess the accuracy of magnetic resonance imaging (MRI) in evaluating residual
disease after neoadjuvant chemotherapy in patients with large breast cancers. MATERIALS …

Purpose. To compare the value of conventional imaging modalities and MRI for
determination of response to neoadjuvant chemotherapy for breast cancer. Material and …

Contrast-enhanced magnetic resonance imaging (MRI) was used to monitor the response of
patients undergoing neoadjuvant chemotherapy for breast cancer with the aim of …

OBJECTIVE. This study was undertaken to evaluate the ability of MRI to accurately show
residual primary breast malignancy in women treated with neoadjuvant chemotherapy …

Objectives This systematic review aimed to assess the role of magnetic resonance imaging
(MRI) in evaluating residual disease extent and the ability to detect pathologic complete …

OBJECTIVE. Our study investigated the usefulness of contrast-enhanced MR imaging for
accurately measuring the size of residual tumor after patients have undergone neoadjuvant …